Search - tctmd.com

Displaying 461 - 480 of 59353

Sort: Relevancy | Date

Presentation THT 2026

First Few Days in the Hospital — How Do We Tackle Those With Diuretic Resistance?

Presenter: Jeffrey Testani

March 02, 2026

Presentation THT 2026

Increased Psoas Muscle Recovery After LVAD Implantation Is Associated with Decreased Major Bleed Readmission in Cardiogenic Shock Patients

Presenter: Robert Anthony Adamian

March 02, 2026

Presentation THT 2026

Characteristics and Long-Term Outcomes of Left Ventricular Assist Device Patients with an Implanted Pulmonary Artery Pressure Sensor: Insights from the Hemodynamic Frontiers in Heart Failure (HF2) Registry

Presenter: Elizabeth Volz

March 02, 2026

Presentation THT 2026

Case Resolution

Presenter: Yousif Al-Saiegh

March 02, 2026

Presentation THT 2026

Treating AHF in the ER — Is There Anything Beyond Furosemide?

Presenter: Daniel R. Bensimhon

March 02, 2026

Presentation THT 2026

Framing Thoughts From the Expert

Presenter: Rajiv Tayal

March 02, 2026

Presentation THT 2026

Targeting ventricular efficiency in heart failure patients: Using simulation to define the best therapeutic intervention

Presenter: Rohan Goswami

March 02, 2026

Presentation THT 2026

Physician-Directed Patient Self-Management of Heart Failure Using Left Atrial Pressure: Early Experience from the U.S. and Europe

Presenter: Nir Ayalon

March 02, 2026

Presentation THT 2026

Case Presentation

Presenter: Yousif Al-Saiegh

March 02, 2026

Presentation THT 2026

Worsening heart failure and subsequent heart failure events

Presenter: Michael Stanley Kiernan

March 02, 2026

Presentation THT 2026

Management of Acute Decompensated Valvular Heart Disease

Presenter: Jörg Hausleiter

March 02, 2026

Presentation THT 2026

Impella Use for Ventricular Unloading During VA-ECMO Compared With VA-ECMO Alone: An Analysis of the American Heart Association Cardiogenic Shock Registry (AHA-CSR)

Presenter: Rahul Gunukula

March 02, 2026

Presentation THT 2026

How To Treat AHF Before Admission — Device Based Early Identification and Treatment

Presenter: Liviu Klein

March 02, 2026

Presentation THT 2026

The Role of the Heart in HFpEF

Presenter: Javed Butler

March 02, 2026

Presentation THT 2026

What Causes Inflammation in HFpEF? What Lights the Fire?

Presenter: Mark C. Petrie

March 02, 2026

Presentation THT 2026

The Cardio-Hematopoietic Axis in HFpEF: A Theory of Everything

Presenter: Douglas L. Mann

March 02, 2026

Presentation THT 2026

The Adipokine Hypothesis of HFpEF: A New Unifying Framework

Presenter: Milton Packer

March 02, 2026

Presentation THT 2026

Role of Obesity and Adiposity in HFpEF: Fat Is Where It Is At

Presenter: Barry Borlaug

March 02, 2026

Presentation THT 2026

Session Introduction: Identifying the Root Cause of HFpEF

Presenter: Scott Solomon

March 02, 2026

Presentation THT 2026

Barriers and Opportunities Related to the Introduction of Innovation in Durable MCS Devices

Presenter: Kevin Bourque

March 02, 2026

Advertisement

First Few Days in the Hospital — How Do We Tackle Those With Diuretic Resistance?

Increased Psoas Muscle Recovery After LVAD Implantation Is Associated with Decreased Major Bleed Readmission in Cardiogenic Shock Patients

Characteristics and Long-Term Outcomes of Left Ventricular Assist Device Patients with an Implanted Pulmonary Artery Pressure Sensor: Insights from the Hemodynamic Frontiers in Heart Failure (HF2) Registry

Case Resolution

Treating AHF in the ER — Is There Anything Beyond Furosemide?

Framing Thoughts From the Expert

Targeting ventricular efficiency in heart failure patients: Using simulation to define the best therapeutic intervention

Physician-Directed Patient Self-Management of Heart Failure Using Left Atrial Pressure: Early Experience from the U.S. and Europe

Case Presentation

Worsening heart failure and subsequent heart failure events

Management of Acute Decompensated Valvular Heart Disease

Impella Use for Ventricular Unloading During VA-ECMO Compared With VA-ECMO Alone: An Analysis of the American Heart Association Cardiogenic Shock Registry (AHA-CSR)

How To Treat AHF Before Admission — Device Based Early Identification and Treatment

The Role of the Heart in HFpEF

What Causes Inflammation in HFpEF? What Lights the Fire?

The Cardio-Hematopoietic Axis in HFpEF: A Theory of Everything

The Adipokine Hypothesis of HFpEF: A New Unifying Framework

Role of Obesity and Adiposity in HFpEF: Fat Is Where It Is At

Session Introduction: Identifying the Root Cause of HFpEF

Barriers and Opportunities Related to the Introduction of Innovation in Durable MCS Devices

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content